REG - Tristel PLC - Trading Update <Origin Href="QuoteRef">TSTL.L</Origin>

TristelAnnouncement

06/09/2014 02:05

For best results when printing this announcement, please click on the link
below:

http://pdf.reuters.com/Regnews/regnews.asp?i=43059c3bf0e37541&u=urn:newsml:reuters.com:20140610:nRSJ2034Ja


RNS Number : 2034J
Tristel PLC
10 June 2014 
 
10 June 2014 
 
Tristel plc 
 
("Tristel" or "the Company") 
 
Trading Update 
 
Tristel plc (AIM: TSTL), the manufacturer of infection prevention,
contamination control and hygiene products, provides a trading update for the
year ending 30 June 2014, ahead of previously upgraded expectations announced
in April. 
 
Tristel addresses three distinct markets: Human Healthcare, Animal Healthcare
and Contamination Control, with three distinctively branded product ranges:
Tristel, Anistel and Crystel. 
 
Tristel announced in both March and April that it was experiencing strong
momentum in its underlying business.  This trend is expected to continue
through to its June year end and beyond. 
 
The Company now anticipates further acceleration in revenue growth and as a
consequence has raised its internal expectations both for the current and
subsequent financial years. Pre-tax profit (before share-based payments) for
the year ending 30 June 2014 is now expected to be not less than £1.75m (2013:
£0.48m adjusted pre-tax profit*). 
 
Paul Swinney, Chief Executive, comments "We are experiencing a rise in sales
in all three portfolios and across most geographical markets. The pace of
growth is higher than previously anticipated and with margins also improving
and costs stable, the impact on the bottom line is both significant and
immediate. 
 
"We can conclude that the re-shaping of our business over the past three years
has been firmly cemented in place. The growing revenue contributions from the
new products and new markets we have invested in have become both visible and
predictable, and with an exciting pipeline of new innovations built upon our
proprietary chlorine dioxide technology, we view the future with increasing
confidence." 
 
*Adjusted for non-recurring items of £2.2m 
 
For further information please contact: 
 
 Tristel plc                             Tel: 01638 721 500                            
 Paul Swinney, Chief Executive Officer                                                 
 Liz Dixon, Finance Director                                                           
                                                                                       
 Walbrook PR Ltd                         Tel: 020 7933 8780 or tristel@walbrookpr.com  
 Paul McManus                            Mob: 07980 541 893                            
                                                                                       
 finnCap                                 Tel: 020 7600 1658                            
 Geoff Nash (Corporate Finance)                                                        
 Charlotte Stranner (Corporate Finance)                                                
 Stephen Norcross (Corporate Broking)                                                  
 
 
This information is provided by RNS
The company news service from the London Stock Exchange